The Channel Island of Jersey supplied Germany’s medical cannabis market with more flower than Colombia last year, recent data shows.
All exports came from one single cultivator, accounting for around 90% of the island’s total output and putting Jersey on the map as one of the leading producers of medical cannabis per capita.
Since the introduction of Germany’s cannabis reforms in April 2024, which partially legalised adult-use and simplified access for patients, the country has seen a surge in demand for prescriptions, solidifying its position as Europe’s largest and most developed market.
Data released by Germany’s Ministry of Health in March shows imports of medical cannabis surpassed 200 tonnes for the first time last year, nearly triple 2024’s total.
But the figures also point to subtle changes in supply chain dynamics.
While overall imports fell by approximately 4.5% in the final quarter, exports from the UK (including the British Channel Islands) increased by more than 11 times year-on-year, reaching over 1,500kg in Q4, the highest quarterly total on record.
Speaking to Business of Cannabis previously, analysts at Prohibition Partners identified “stronger supply chains” emerging from UK exporters — and “primarily Jersey”.
